George Daniel Pins

Dr. George Daniel Pins

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1997 in Biophysical Journal
Verified
Journal Article
Closed access
GPGeorge Daniel Pins
George Daniel Pins
DCD.L. Christiansen
D.L. Christiansen
RPR. Patel
R. Patel
FSF.H. Silver
F.H. Silver

1 October 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
Jonathan GrasmanJonathan Grasman
Jonathan Grasman
MZMichelle J. Zayas
Michelle J. Zayas
RPRaymond L. Page
Raymond L. Page
GPGeorge Daniel Pins
George Daniel Pins

13 December 2006 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
KCKevin G. Cornwell
Kevin G. Cornwell
PLPedro Lei
Pedro Lei
SAStelios T. Andreadis
Stelios T. Andreadis
GPGeorge Daniel Pins
George Daniel Pins

31 July 2020 in Bioengineering
Verified
Journal Article
Open access
PDF file
MCMeagan Carnes
Meagan Carnes
GPGeorge Daniel Pins
George Daniel Pins
Millions of Americans suffer from skeletal muscle injuries annually that can result in volumetric muscle loss (VML), where extensive musculoskeletal damage and tissue loss result in permanent functional deficits. In the case of small-scale injury skeletal muscle is capable of endogenous regeneration through activation of resident satellite cells (SCs). However, this is greatly reduced in VML injuries, which remove native biophysical and biochemical signaling cues and hinder the damaged tissue’s ability to direct regeneration. The current clinical treatment for VML is autologous tissue transfer, but graft failure and scar tissue formation leave patients with limited functional recovery. Tissue engineering of instructive biomaterial scaffolds offers a promising approach for treating VML injuries. Herein, we review the strategic engineering of biophysical and biochemical cues in current scaffold designs that aid in restoring function to these preclinical VML injuries. We also discuss the successes and limitations of the three main biomaterial-based strategies to treat VML injuries: acellular scaffolds, cell-delivery scaffolds, and in vitro tissue engineered constructs. Finally, we examine several innovative approaches to enhancing the design of the next generation of engineered scaffolds to improve the functional regeneration of skeletal muscle following VML injuries.

1 June 1994 in Biomaterials
Verified
Journal Article
Closed access
WMWang Ming-Che
Wang Ming-Che
GPGeorge Daniel Pins
George Daniel Pins
FSFrederick H. Silver
Frederick H. Silver

1 January 1995 in Biomaterials
Verified
Journal Article
Closed access
FSFrederick H. Silver
Frederick H. Silver
MWMing-Che Wang
Ming-Che Wang
GPGeorge Daniel Pins
George Daniel Pins